The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Evidence · Trials

Reading a supplementary appendix and finding the interesting part

PK
p.krastevTL229 Sep 2024#1

Reading a supplementary appendix and finding the interesting part — setting out what I have, and where I think it stops being reliable.

Collecting what is known about reading a supplementary appendix in one place, because it is currently spread across a category, two tag pages and a thread that is hard to find.

This is a summary rather than new work, and I have attributed each part to where I found it.

52 likes 22mo
EI
e.iyerTL23 Oct 2024#2

Confirming the opening post from a second method, which matters more than confirming it from a second person.

Two sentences on reading a supplementary appendix and then I will stop, because the rest is speculation and the thread is better without mine.

What is documented is narrow. What is inferred from it is broad. The gap between them is where every argument here lives.

14 likes 22mo
MH
ms_hollowayTL4Mass spectrometrist6 Oct 2024#3

On the opening post — agreed on the reasoning, with one qualification.

Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between them tells you how many people benefit.

5 likes 22mo
NS
n.silvaTL29 Oct 2024#4
ms_holloway, post #3: On the opening post — agreed on the reasoning, with one qualification. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between them tells you how many people benefit. Go to post

Reading a supplementary appendix: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.

0 likes in reply to #3 22mo
HO
h.oyelowoTL2Regular11 Oct 2024 · edited#5
n.silva, post #4: Reading a supplementary appendix: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this. Go to post

Filing a mild objection to the consensus on reading a supplementary appendix. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.

21 likes in reply to #4 22mo
RB
r.bruunTL214 Oct 2024#6

Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment), concealment (could randomisation be subverted), blinding (who was blinded and why or why not), completeness of outcome reporting.

For what it is worth, the same held on the two occasions I checked.

9 likes 21mo
SC
sourced_claimsTL316 Oct 2024#7
CC
ch.correiaTL218 Oct 2024#8

This follows post #6 rather than contradicting it.

I would be cautious about generalising from the reading a supplementary appendix example above. It is a good example. It is one example.

0 likes 21mo
QL
quiet_lurkerTL2Regular20 Oct 2024#9
ch.correia, post #8: This follows post #6 rather than contradicting it. I would be cautious about generalising from the reading a supplementary appendix example above. It is a good example. It is one example. Go to post

Discontinuation handling is the methodological detail that most changes a result and gets the least attention. Read how missing data was imputed before reading the effect size.

14 likes in reply to #8 21mo
JB
j.bhattacharyaTL222 Oct 2024#10

A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened had everyone continued. Both are legitimate and they give different numbers.

If anyone has run this properly I would rather read that than my own guess.

5 likes 21mo
KM
k.marchandTL224 Oct 2024#11

Picking up post #8: that is the part I would want checked first.

Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from those two numbers.

Old habit: I write down the expected answer before I calculate it.

0 likes 21mo
FT
fr.translation_moTL2Translator · FR26 Oct 2024#12
e.iyer, post #2: Confirming the opening post from a second method, which matters more than confirming it from a second person. Two sentences on reading a supplementary appendix and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred from it is broad. The gap between them… Go to post

The documentation on reading a supplementary appendix is better than this thread and I say that as someone who has posted in the thread.

1 like in reply to #2 21mo
AD
a.delgadoTL228 Oct 2024#13

What would change my mind on reading a supplementary appendix is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more.

6 likes 21mo
MH
m.haddadTL2Regular29 Oct 2024#14

A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened had everyone continued. Both are legitimate and they give different numbers.

The general answer and the answer for your case may diverge here.

17 likes 21mo
SA
s.adebayoTL231 Oct 2024 · edited#15

Two claims get bundled together under reading a supplementary appendix and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one — this is why — usually is not.

Almost every disagreement in threads like this one dissolves once you say which of the two you are making.

32 likes 21mo
WP
weekly_pinTL2Regular2 Nov 2024#16
quiet_lurker, post #9: Discontinuation handling is the methodological detail that most changes a result and gets the least attention. Read how missing data was imputed before reading the effect size. Go to post

No notes. Posting so the count is not one.

0 likes in reply to #9 21mo
HL
h.lindqvistTL24 Nov 2024#17

Reading the supplementary appendix is where most of the real information is, and it is where almost nobody goes. The baseline table alone answers half the generalisability questions asked here.

That is the version I would defend. It is not the version I started with.

3 likes 21mo
AD
appeals_deskTL3Regular5 Nov 2024#18

I read post #14 twice before replying, because I had assumed the opposite.

On reading a supplementary appendix, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting bit.

If you can post the two or three numbers you are working from, several people here will check the arithmetic rather than argue about the conclusion.

11 likes 21mo
DA
d.achebeTL27 Nov 2024#19
a.delgado, post #13: What would change my mind on reading a supplementary appendix is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more. Go to post

Reading a supplementary appendix has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.

1 like in reply to #13 21mo
D
DKwiatkowskiTL3Regular9 Nov 2024#20

Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between them tells you how many people benefit.

The rule of thumb is fine; the edge cases are where it earns its keep.

6 likes 21mo
CG
c.grimaldiTL210 Nov 2024#21

Worth separating two things that post #19 runs together.

Adding a reference point for reading a supplementary appendix. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.

0 likes 21mo
CC
c.cardosoTL212 Nov 2024#22

This follows post #19 rather than contradicting it.

Genuine question rather than a rhetorical one: has anyone here actually observed reading a supplementary appendix, as opposed to read about it? The thread is long and I cannot tell.

0 likes 20mo
ML
m.lehtinenTL214 Nov 2024#23
h.lindqvist, post #17: Reading the supplementary appendix is where most of the real information is, and it is where almost nobody goes. The baseline table alone answers half the generalisability questions asked here. That is the version I would defend. It is not the version I started with. Go to post

Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment), concealment (could randomisation be subverted), blinding (who was blinded and why or why not), completeness of outcome reporting.

12 likes in reply to #17 20mo
NN
n.nybergTL215 Nov 2024#24
fr.translation_mo, post #12: The documentation on reading a supplementary appendix is better than this thread and I say that as someone who has posted in the thread. Go to post

A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened had everyone continued. Both are legitimate and they give different numbers.

Noting that the question and the thing people usually mean by it are different.

4 likes in reply to #12 20mo
NB
n.brobergTL217 Nov 2024#25

Post #23 and I disagree about the size of the effect, not about the direction.

One more thing on reading a supplementary appendix that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent contradiction disappears.

1 like 20mo
PW
PharmNotes_WhitfieldTL4Pharmacist18 Nov 2024#26

I would call the community position on reading a supplementary appendix likely rather than established, and I would be comfortable defending that hedge.

0 likes 20mo
JF
j.fonsecaTL220 Nov 2024#27
DO
dr_okonkwoTL4 Moderator21 Nov 2024#28
h.lindqvist, post #17: Reading the supplementary appendix is where most of the real information is, and it is where almost nobody goes. The baseline table alone answers half the generalisability questions asked here. That is the version I would defend. It is not the version I started with. Go to post

Narrowing post #26, because the general version has more than one answer.

The failure mode on reading a supplementary appendix is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.

7 likes in reply to #17 20mo
RF
ro.friskTL223 Nov 2024#29

If someone has run reading a supplementary appendix properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.

0 likes 20mo
DS
dr_seongTL3Physician24 Nov 2024#30
h.oyelowo, post #5: Filing a mild objection to the consensus on reading a supplementary appendix. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Go to post

Composite endpoints should be read component by component. A composite driven entirely by its softest component is a different finding from one where the components move together.

18 likes in reply to #5 20mo